Juno Awarded Over $1.1B In Final Judgment For IP Case
A California federal judge on Wednesday entered final judgment awarding Juno Therapeutics and Sloan Kettering enhanced damages of over $389 million while boosting the total award to over $1.1 billion after...To view the full article, register now.
Already a subscriber? Click here to view full article